Biomarkers for pediatric sepsis and septic shock

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 1, 2011, Pages 71-79

  Standage, Stephen W ^a   Wong, Hector R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

biomarker; C reactive protein; CCL4; CD64; IL 18; IL 8; lactate; procalcitonin; sepsis; septic shock

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD64 ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 8; LACTIC ACID; PROCALCITONIN;

CLINICAL ASSESSMENT; GENE EXPRESSION PROFILING; HUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; INFLAMMATION; INTERLEUKIN-18; LACTATES; PROTEIN PRECURSORS; RECEPTORS, IGG; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 78650649962     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.154     Document Type: Review

References (63)

1. Goldstein B, Giroir B, Randolph A International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in Pediatr. Crit. Care Med. 6(1), 2-8 (2005).
2. Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31(4), 1250-1256 (2003).
3. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36(1), 296-327 (2008).
4. Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit. Care Med. 37(2), 666-688 (2009).
5. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69(3), 89-95 (2001).
6. Marshall JC, Reinhart K. Biomarkers of sepsis. Crit. Care Med. 37(7), 2290-2298 (2009).
7. Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr. Crit. Care Med. (2010) (Epub ahead of print).
8. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit. Care Med. 36(3), 941-952 (2008).
9. Arkader R, Troster EJ, Lopes MR, et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch. Dis. Child. 91(2), 117-120 (2006).
10. Casado-Flores J, Blanco-Quirós A, Asensio J, et al. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr. Crit. Care Med. 4(2), 190-195 (2003).
11. Fioretto JR, Martin JG, Kurokawa CS, et al. Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock. Inflamm. Res. 59(8), 581-586 (2010).
12. Rey C, Los Arcos M, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med. 33(3), 477-484 (2007).
13. Simon L, Saint-Louis P, Amre DK, Lacroix J, Gauvin F. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr. Crit. Care Med. 9(4), 407-413 (2008).
14. Carrol ED, Newland P, Thomson APJ, Hart CA. Prognostic value of procalcitonin in children with meningococcal sepsis. Crit. Care Med. 33(1), 224-225 (2005).
15. Enguix A, Rey C, Concha A, et al. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med. 27(1), 211-215 (2001).
16. Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, et al. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 35(11), 1950-1958 (2009).
17. Han YY, Doughty LA, Kofos D, Sasser H, Carcillo JA. Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis. Pediatr. Crit. Care Med. 4(1), 21-25 (2003).
18. Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit. Care Med. 28(7), 2591-2594 (2000).
19. Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitoninguided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med. 38(11), 2229-2241 (2010).
20. Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology 97(2), 165-174 (2010).
21. Arkader R, Troster EJ, Abellan DM, et al. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J. Cardiothorac. Vasc. Anesth. 18(2), 160-165 (2004).
22. McMaster P, Park DY, Shann F, et al. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in children. Pediatr. Crit. Care Med. 10(2), 217-221 (2009).
23. Neely AN, Fowler LA, Kagan RJ, Warden GD. Procalcitonin in pediatric burn patients: an early indicator of sepsis? J. Burn Care Rehabil. 25(1), 76-80 (2004).
24. Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns DOI:10.1016/j.burns.2010.04.013 (2010) (Epub ahead of print).
25. Coelho MCM, Tannuri U, Tannuri ACA, Reingenheim C, Troster EJ. Is procalcitonin useful to differentiate rejection from bacterial infection in the early post-operative period of liver transplantation in children? Pediatr. Transplant. 13(8), 1004-1006 (2009).
26. Hatzistilianou M, Rekliti A, Athanassiadou F, Catriu D. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm. Res. 59(5), 339-347 (2010).
27. Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur. J. Clin. Microbiol. Infect. Dis. 25(6), 413-415 (2006).
28. Sauer M, Tiede K, Fuchs D, et al. Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant. 31(12), 1137-1142 (2003).
29. Stryjewski GR, Nylen ES, Bell MJ, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr. Crit. Care Med. 6(2), 129-135 (2005).
30. Carrol ED, Mankhambo LA, Jeffers G, et al. The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection. PLoS ONE 4(8), e6621 (2009).
31. Chiesa C, Panero A, Rossi N, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin. Infect. Dis. 26(3), 664-672 (1998).
32. Chiesa C, Pacifico L, Rossi N, et al. Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit. Intensive Care Med. 26(Suppl. 2), S175-S177 (2000).
33. Monneret G, Labaune JM, Isaac C, et al. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr. 86(2), 209-212 (1997).
34. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Schimmel MS. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Paediatr. 95(12), 1571-1576 (2006).
35. Resch B, Gusenleitner W, Mller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr. 92(2), 243-245 (2003).
36. Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J. Pediatr. 128(4), 570-573 (1996).
37. Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet 351(9110), 1211-1212 (1998).
38. Monneret G, Labaune JM, Isaac C, et al. Increased serum procalcitonin levels are not specific to sepsis in neonates. Clin. Infect. Dis. 27(6), 1559-1561 (1998).
39. Turner D, Hammerman C, Rudensky B, et al. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch. Dis. Child. Fetal Neonatal Ed. 91(4), F283-F286 (2006).
40. Bhandari V, Wang C, Rinder C, Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 121(1), 129-134 (2008).
41. Lam HS, Wong SPS, Cheung HM, et al. Early diagnosis of intra-abdominal inflammation and sepsis by neutrophil CD64 expression in newborns. Neonatology 99(2), 118-124 (2010).
42. Rudensky B, Sirota G, Erlichman M, Yinnon AM, Schlesinger Y. Neutrophil CD64 expression as a diagnostic marker of bacterial infection in febrile children presenting to a hospital emergency department. Pediatr. Emerg. Care 24(11), 745-748 (2008).
43. Cid J, Aguinaco R, Sánchez R, García- Pardo G, Llorente A. Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J. Infect. 60(5), 313-319 (2010).
44. Kingsmore SF, Kennedy N, Halliday HL, et al. Identification of diagnostic biomarkers for infection in premature neonates. Mol. Cell Proteomics 7(10), 1863-1875 (2008).
45. Bender L, Thaarup J, Varming K, et al. Early and late markers for the detection of early-onset neonatal sepsis. Dan. Med. Bull. 55(4), 219-223 (2008).
46. Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit. Care Med. 20(1), 80-93 (1992).
47. Fall PJ, Szerlip HM. Lactic acidosis: from sour milk to septic shock. J. Intensive Care Med. 20(5), 255-271 (2005).
48. Dugas MA, Proulx F, de Jaeger A, Lacroix J, Lambert M. Markers of tissue hypoperfusion in pediatric septic shock. Intensive Care Med. 26(1), 75-83 (2000).
49. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit. Care Med. 37(5), 1670-1677 (2009).
50. Jansen TC, van Bommel J, Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit. Care Med. 37(10), 2827-2839 (2009).
51. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit. Care Med. 32(8), 1637-1642 (2004).
52. Brown SD, Clark C, Gutierrez G. Pulmonary lactate release in patients with sepsis and the adult respiratory distress syndrome. J. Crit. Care 11(1), 2-8 (1996).
53. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 354(9177), 505-508 (1999).
54. Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 32(1), 35-39 (2009).
55. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303(8), 739-746 (2010).
56. Kofoed K, Andersen O, Kronborg G, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 11(2), R38 (2007).
57. Marshall JC. Sepsis: rethinking the approach to clinical research. J. Leukoc. Biol. 83(3), 471-482 (2008).
58. Wong HR, Cvijanovich N, Wheeler DS, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am. J. Respir. Crit. Care Med. 178(3), 276-282 (2008).
59. Wong HR, Shanley TP, Sakthivel B, et al. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol. Genomics 30(2), 146-155 (2007).
60. Nadel S, Goldstein B, Williams MD, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre Phase III randomised controlled trial. Lancet 369(9564), 836-843 (2007).
61. Nowak JE, Wheeler DS, Harmon KK, Wong HR. Admission chemokine (C-C motif ) ligand 4 levels predict survival in pediatric septic shock. Pediatr. Crit. Care Med. 11(2), 213-216 (2010).
62. Calfee CS, Thompson BT, Parsons PE, et al. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Crit. Care Med. 38(6), 1436-1441 (2010).
63. Wong HR, Cvijanovich N, Lin R, et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med. 7, 34 (2009).